Clinical trials
Expanded access Breast Neoplasms trials in the United States
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
6 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2006 | 1 |
| 2010 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Approved for marketing | 3 |
| Available | 2 |
| No longer available | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Eli Lilly and Company | 2 |
| Genentech, Inc. | 2 |
| Aveni Foundation | 1 |
| Novartis | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Breast Neoplasms | 6 |
| Carcinoma, Non-Small-Cell Lung | 2 |
| Pancreatic Neoplasms | 2 |
| Carcinoma, Medullary | 1 |
| Chondrosarcoma | 1 |
| Chordoma | 1 |
| Colonic Neoplasms | 1 |
| Neoplasm Metastasis | 1 |
| Neurofibrosarcoma | 1 |
| Osteosarcoma | 1 |
Trials
Showing 1 to 6 of 6. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.